Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-arterial Tenecteplase for Acute Basilar Artery Occlusion
NCT05580822Phase 2Not yet recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Jan 2023
- Primary completion
- Dec 2024
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 2 trial of tenecteplase in basilar artery occlusion (BAO), sponsored by First Hospital of China Medical University. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
tenecteplase
03
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT05580822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05580822.